FDA Brief

Warning letters Drugs

FDA warning letter to

Exela Pharma Sciences, LLC

Issued Jul 2, 2025Posted Jul 3, 2025Center for Drug Evaluation and Research (CDER)

CGMP/Finished Pharmaceuticals/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.

Exela Pharma Sciences, LLC's FDA history

  1. Exela Pharma Sciences LLC

    Unapproved New Drug/Compounding/Misbranding

Full company page